Syn stock news trial#

Syn stock news trial#

Louis to conduct a Phase 1b/2a clinical trial of SYN-004. It has collaborations with Intrexon Corporation, The University of Texas at Austin, and Cedars-Sinai Medical Center and a clinical trial agreement with Washington University School of Medicine in St. as traders can mimic a long position in a stock using options without having. The 2 analysts offering 12-month price forecasts for Synthetic Biologics Inc have a median target of 6.00, with a high estimate of 8.00. In addition, the company develops clinical stage products, such as SYN-006 to prevent aGVHD and infection by carbapenem resistant enterococci SYN-007 for preventing antibiotic associated diarrhea with oral ß-lactam antibiotics SYN-005 for the prevention and treatment of pertussis and VCN-11 to treat cancer. Synthetic is the term given to financial instruments that are engineered to. It also develops VCN-01 for the treatment of patients with pancreatic cancer, head and neck squamous cell carcinoma, colorectal cancer, and retinoblastoma. Synthetic Biologics, Inc., a clinical-stage company. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile infection (CDI), overgrowth of pathogenic organisms, the emergence of antimicrobial resistance (AMR), and acute graft-versus-host-disease (aGVHD) in allogeneic hematopoietic cell transplant recipients and SYN-020, a recombinant oral formulation for the enzyme intestinal alkaline phosphatase to treat both local GI and systemic diseases. Research Synthetic Biologics (SYN) stock with daily updated analysis. Investing ideas, stock information, fundamental analysis, technical analysis on SYNTHETIC BIOLOGICS INC (SYN) from SE Asias most active stock investing.

Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. Stock analysis for Synthetic Biologics Inc (SYN:NYSEAmerican) including stock price, stock chart, company news, key statistics, fundamentals and company.